Assessment of the Bone Healing Process Mediated by Periosteum-Derived Mesenchymal Stem Cells' Secretome and a Xenogenic Bioceramic-An In Vivo Study in the Rabbit Critical Size Calvarial Defect Model

Overview

Journal Materials (Basel)

Publisher MDPI

Date 2021 Jul 2

PMID 34202509

Citations 6

Authors

Mindaugas Pranskunas

Egidijus Simoliunas

Milda Alksne

Victor Martin

Pedro Sousa Gomes

Algirdas Puisys

Algirdas Kaupinis

Gintaras Juodzbalys

Affiliations

Soon will be listed here.

Abstract

The mesenchymal stem cell (MSC) secretome has been considered an innovative therapeutic biological approach, able to modulate cellular crosstalk and functionality for enhanced tissue repair and regeneration. This study aims to evaluate the functionality of the secretome isolated from periosteum-derived MSCs, from either basal or osteogenic-induced conditions, in the healing of a critical size calvarial bone defect in the rabbit model. A bioceramic xenograft was used as the vehicle for secretome delivery, and the biological response to the established biocomposite system was assessed by clinical, histological, histomorphometric, and microtomographic analysis. A comparative analysis revealed that the osteogenic-induced secretome presented an increased diversity of proteins, with emphasis on those related to osteogenesis. Microtomographic and histological morphometric analysis revealed that bioceramic xenografts implanted with secretomes enhanced the new bone formation process, with the osteogenic-induced secretome inducing the highest bone tissue formation. The application of the MSC secretome, particularly from osteogenic-induced populations, may be regarded as an effective therapeutic approach to enhance bone tissue healing and regeneration.

Citing Articles

Targeting micromotion for mimicking natural bone healing by using NIPAM/NbC hydrogel.

Yang Q, Xu M, Fang H, Gao Y, Zhu D, Wang J Bioact Mater. 2024; 39:41-58.

PMID: 38800718 PMC: 11127186. DOI: 10.1016/j.bioactmat.2024.05.023.

Stem Cells and Bone Tissue Engineering.

Gao X, Ruzbarsky J, Layne J, Xiao X, Huard J Life (Basel). 2024; 14(3).

PMID: 38541613 PMC: 10971350. DOI: 10.3390/life14030287.

Potential Utilisation of Secretome from Ascorbic Acid-Supplemented Stem Cells in Combating Skin Aging: Systematic Review of A Novel Idea.

Wahyuningsih K, Pangkahila W, Weta I, Widiana I, Wahyuniari I Cell J. 2023; 25(9):591-602.

PMID: 37718762 PMC: 10520989. DOI: 10.22074/cellj.2023.1995999.1253.

Discovery of multipotent progenitor cells from human induced membrane: Equivalent to periosteum-derived stem cells in bone regeneration.

Wu H, Tan J, Sun D, Wang X, Shen J, Wang S J Orthop Translat. 2023; 42:82-93.

PMID: 37705762 PMC: 10495554. DOI: 10.1016/j.jot.2023.07.004.

Effect of Splinting on Orthodontic Mini-Implant Tipping and Bone Histomorphometric Parameters: An In Vivo Animal Model Study.

Fontes J, Martin V, Resende M, Colaco B, Sousa Gomes P, Amarante J J Funct Biomater. 2023; 14(5).

PMID: 37233349 PMC: 10219099. DOI: 10.3390/jfb14050239.

References

Katagiri W, Osugi M, Kawai T, Ueda M . Novel cell-free regeneration of bone using stem cell-derived growth factors. Int J Oral Maxillofac Implants. 2013; 28(4):1009-16. DOI: 10.11607/jomi.3036. View

Choi Y, Lim J, Kim K, Acharya B, Cho J, Bae Y . Secretome analysis of human BMSCs and identification of SMOC1 as an important ECM protein in osteoblast differentiation. J Proteome Res. 2010; 9(6):2946-56. DOI: 10.1021/pr901110q. View

Weiss D, Bates J, Gilbert T, Liles W, Lutzko C, Rajagopal J . Stem cells and cell therapies in lung biology and diseases: conference report. Ann Am Thorac Soc. 2013; 10(5):S25-44. PMC: 5475419. DOI: 10.1513/AnnalsATS.201304-089AW. View

Petrenko Y, Vackova I, Kekulova K, Chudickova M, Koci Z, Turnovcova K . A Comparative Analysis of Multipotent Mesenchymal Stromal Cells derived from Different Sources, with a Focus on Neuroregenerative Potential. Sci Rep. 2020; 10(1):4290. PMC: 7062771. DOI: 10.1038/s41598-020-61167-z. View

Hutmacher D, Sittinger M . Periosteal cells in bone tissue engineering. Tissue Eng. 2003; 9 Suppl 1:S45-64. DOI: 10.1089/10763270360696978. View

Yong K, Choi J, Dolbashid A, Safwani W . Biosafety and bioefficacy assessment of human mesenchymal stem cells: what do we know so far?. Regen Med. 2018; 13(2):219-232. DOI: 10.2217/rme-2017-0078. View

Pires A, Mendes-Pinheiro B, Teixeira F, Anjo S, Ribeiro-Samy S, Gomes E . Unveiling the Differences of Secretome of Human Bone Marrow Mesenchymal Stem Cells, Adipose Tissue-Derived Stem Cells, and Human Umbilical Cord Perivascular Cells: A Proteomic Analysis. Stem Cells Dev. 2016; 25(14):1073-83. DOI: 10.1089/scd.2016.0048. View

Kusuma G, Carthew J, Lim R, Frith J . Effect of the Microenvironment on Mesenchymal Stem Cell Paracrine Signaling: Opportunities to Engineer the Therapeutic Effect. Stem Cells Dev. 2017; 26(9):617-631. DOI: 10.1089/scd.2016.0349. View

Wisniewski J, Zougman A, Nagaraj N, Mann M . Universal sample preparation method for proteome analysis. Nat Methods. 2009; 6(5):359-62. DOI: 10.1038/nmeth.1322. View

10.

Frame J . A convenient animal model for testing bone substitute materials. J Oral Surg. 1980; 38(3):176-80. View

11.

Coelho M, Fernandes M . Human bone cell cultures in biocompatibility testing. Part II: effect of ascorbic acid, beta-glycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials. 2000; 21(11):1095-102. DOI: 10.1016/s0142-9612(99)00192-1. View

12.

Villatoro A, Alcoholado C, Martin-Astorga M, Fernandez V, Cifuentes M, Becerra J . Comparative analysis and characterization of soluble factors and exosomes from cultured adipose tissue and bone marrow mesenchymal stem cells in canine species. Vet Immunol Immunopathol. 2019; 208:6-15. DOI: 10.1016/j.vetimm.2018.12.003. View

13.

Kim S, Muise A, Lyons P, Ro H . Regulation of adipogenesis by a transcriptional repressor that modulates MAPK activation. J Biol Chem. 2001; 276(13):10199-206. DOI: 10.1074/jbc.M010640200. View

14.

Delgado-Ruiz R, Calvo-Guirado J, Romanos G . Critical size defects for bone regeneration experiments in rabbit calvariae: systematic review and quality evaluation using ARRIVE guidelines. Clin Oral Implants Res. 2014; 26(8):915-930. DOI: 10.1111/clr.12406. View

15.

Yoshiko Y, Aubin J . Stanniocalcin 1 as a pleiotropic factor in mammals. Peptides. 2004; 25(10):1663-9. DOI: 10.1016/j.peptides.2004.04.015. View

16.

Sacchetti B, Funari A, Remoli C, Giannicola G, Kogler G, Liedtke S . No Identical "Mesenchymal Stem Cells" at Different Times and Sites: Human Committed Progenitors of Distinct Origin and Differentiation Potential Are Incorporated as Adventitial Cells in Microvessels. Stem Cell Reports. 2016; 6(6):897-913. PMC: 4912436. DOI: 10.1016/j.stemcr.2016.05.011. View

17.

Kotobuki N, Katsube Y, Katou Y, Tadokoro M, Hirose M, Ohgushi H . In vivo survival and osteogenic differentiation of allogeneic rat bone marrow mesenchymal stem cells (MSCs). Cell Transplant. 2008; 17(6):705-12. DOI: 10.3727/096368908786092793. View

18.

Lukomska B, Stanaszek L, Zuba-Surma E, Legosz P, Sarzynska S, Drela K . Challenges and Controversies in Human Mesenchymal Stem Cell Therapy. Stem Cells Int. 2019; 2019:9628536. PMC: 6481040. DOI: 10.1155/2019/9628536. View

19.

Catros S, Sandgren R, Pippenger B, Fricain J, Herber V, El Chaar E . A Novel Xenograft Bone Substitute Supports Stable Bone Formation in Circumferential Defects Around Dental Implants in Minipigs. Int J Oral Maxillofac Implants. 2020; 35(6):1122-1131. DOI: 10.11607/jomi.8265. View

20.

Dwek J . The periosteum: what is it, where is it, and what mimics it in its absence?. Skeletal Radiol. 2010; 39(4):319-23. PMC: 2826636. DOI: 10.1007/s00256-009-0849-9. View